We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

3D-printed All-liquid "Lab-on-a-Chip" Could Transform Drug Candidate Screens

News   Apr 26, 2019 | Original story from DOE’s Lawrence Berkeley National Laboratory

 
3D-printed All-liquid "Lab-on-a-Chip" Could Transform Drug Candidate Screens

To make the 3D-printable fluidic device, Berkeley Lab researchers designed a specially patterned glass substrate. When two liquids - one containing nanoscale clay particles, another containing polymer particles - are printed onto the substrate, they come together at the interface of the two liquids and within milliseconds form a very thin channel or tube about 1 millimeter in diameter. Credit: Berkeley Lab

 
 
Advertisement
 

RELATED ARTICLES

KRAS Inhibitor Sotorasib Achieves Durable Clinical Benefit in Early Trial

News

In a Phase I clinical trial for patients with advanced solid cancers marked by KRAS G12C mutations, the KRASG12C inhibitor sotorasib (AMG 510) resulted in manageable toxicities and durable clinical benefit.

READ MORE

Acoustically Actuated Microscopic Device Developed

News

Researchers at EPFL have developed remote-controlled, mechanical microdevices that, when inserted into human tissue, can manipulate the fluid that surrounds them, collect cells or release drugs. This breakthrough offers numerous potential applications in the biomedical field, from diagnostics to therapy.

READ MORE

Drug Shown To Modulate the Inflammatory Response in Severe COVID-19

News

Scientists have identified a new drug that could prevent or mitigate the consequences derived from SARS-CoV-2 infection.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE